Nincy Debeuf
- Work address
-
Technologiepark Zwijnaarde 71
9052 Zwijnaarde - Nincy.Debeuf@UGent.be
Show
Sort by
-
- Miscellaneous
- open access
A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19
-
- Journal Article
- A1
- open access
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
-
- Journal Article
- A1
- open access
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial
-
- Journal Article
- A1
- open access
Emerging paradigms in type 2 immunity
-
The STE20 kinase TAOK3 controls the development of house dust mite-induced asthma in mice
-
IRE1 beta does not affect mucus secretion during allergic asthma development in a house dust mite murine model
-
Inflammatory type 2 cDCs acquire features of cDC1s and macrophages to orchestrate immunity to respiratory virus infection
-
- Journal Article
- A1
- open access
The ORMDL3 asthma susceptibility gene regulates systemic ceramide levels without altering key asthma features in mice
-
ORMDL3 in the regulation of sphingolipid synthesis and in the pathogenesis of allergic asthma
(2019) -
- Journal Article
- A1
- open access
Eicosanoid control over antigen presenting cells in asthma